Question | Discussion | References | CME Credit

Case 3: References

  1. St Germain RM, Yigit S, Wells L, Girotto JE, Salazar JC. Cushing syndrome and severe adrenal suppression caused by fluticasone and protease inhibitor combination in an HIV-infected adolescent. AIDS Patient Care STDS. 2007;21:373-7.
    [The following link will open in a new window. PubMed Abstract]
  2. Bhumbra NA, Sahloff EG, Oehrtman SJ, Horner JM. Exogenous Cushing syndrome with inhaled fluticasone in a child receiving lopinavir/ritonavir. Ann Pharmacother. 2007;41:1306-9.
    [The following link will open in a new window. PubMed Abstract]
  3. Gillett MJ, Cameron PU, Nguyen HV, Hurley DM, Mallal SA. Iatrogenic Cushing's syndrome in an HIV-infected patient treated with ritonavir and inhaled fluticasone. AIDS. 2005;19:740-1.
    [The following link will open in a new window. PubMed Abstract]
  4. Samaras K, Pett S, Gowers A, McMurchie M, Cooper DA. Iatrogenic Cushing's syndrome with osteoporosis and secondary adrenal failure in human immunodeficiency virus-infected patients receiving inhaled corticosteroids and ritonavir-boosted protease inhibitors: six cases. J Clin Endocrinol Metab. 2005;90:4394-8.
    [The following link will open in a new window. PubMed Abstract]
  5. Johnson SR, Marion AA, Vrchoticky T, Emmanuel PJ, Lujan-Zilbermann J. Cushing syndrome with secondary adrenal insufficiency from concomitant therapy with ritonavir and fluticasone. J Pediatr. 2006;148:386-8.
    [The following link will open in a new window. PubMed Abstract]
  6. Crothers K, Butt AA, Gibert CL, Rodriguez-Barradas MC, Crystal S, Justice AC; Veterans Aging Cohort 5 Project Team. Increased COPD among HIV-positive compared to HIV-negative veterans. Chest. 2006;130:1326-33.
    [The following link will open in a new window. PubMed Abstract]
  7. Arrington-Sanders R, Hutton N, Siberry GK. Ritonavir-fluticasone interaction causing Cushing syndrome in HIV-infected children and adolescents. Pediatr Infect Dis J. 2006;25:1044-8.
    [The following link will open in a new window. PubMed Abstract]
  8. Pivonello R, De Martino MC, De Leo M, Lombardi G, Colao A. Cushing’s Syndrome. Endocrinol Metab Clin North Am. 2008;37:135-49, ix.
    [The following link will open in a new window. PubMed Abstract]
  9. Hillebrand-Haverkort ME, Prummel MF, ten Veen JH. Ritonavir-induced Cushing’s syndrome in a patient treated with nasal fluticasone. AIDS. 1999;13:1803.
    [The following link will open in a new window. PubMed Abstract]
  10. le Roux C, Beckles MA, Besser GM, Pinching AJ, Davison AG. Cushing’s syndrome secondary to inhaled corticosteroid mimicking HIV-associated lipodystrophy. HIV Med 2001;2:133-5.
    [The following link will open in a new window. PubMed Abstract]
  11. Soldatos G, Sztal-Mazer S, Woolley I, Stockigt J. Exogenous glucocorticoid excess as a result of ritonavir-fluticasone interaction. Intern Med J. 2005;35:67-8.
    [The following link will open in a new window. PubMed Abstract]
  12. Pessanha TM, Campos JM, Barros AC, Pone MV, Garrido JR, Pone SM. Iatrogenic Cushing's syndrome in an adolescent with AIDS on ritonavir and inhaled fluticasone. Case report and literature review. AIDS. 2007;21:529-32.
    [The following link will open in a new window. PubMed Abstract]

[Back to Case 3 Question | Back to Discussion]

CME Credit | Back to Top